Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial.
about
The immunological function of CD52 and its targeting in organ transplantation.Operational tolerance in kidney transplantation and associated biomarkers.Evidence of the immunomodulatory role of dual PI3K/mTOR inhibitors in transplantation: an experimental study in mice.Recipient treatment with acetylcholinesterase inhibitor donepezil attenuates primary graft failure in rats through inhibiting post-transplantational donor heart ischaemia/reperfusion injury.Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board.
P2860
Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Sequential Targeting of CD52 a ...... g in a Proof-Of-Concept Trial.
@ast
Sequential Targeting of CD52 a ...... g in a Proof-Of-Concept Trial.
@en
type
label
Sequential Targeting of CD52 a ...... g in a Proof-Of-Concept Trial.
@ast
Sequential Targeting of CD52 a ...... g in a Proof-Of-Concept Trial.
@en
prefLabel
Sequential Targeting of CD52 a ...... g in a Proof-Of-Concept Trial.
@ast
Sequential Targeting of CD52 a ...... g in a Proof-Of-Concept Trial.
@en
P2093
P2860
P50
P1433
P1476
Sequential Targeting of CD52 a ...... ng in a Proof-Of-Concept Trial
@en
P2093
Bernhard Gerstmayer
Eva Honsova
Irena Tycova
Ondrej Viklicky
Petra Hruba
Petra Mrazova
Sabrina Schmitz
Stefan Tomiuk
Uwe Janssen
P2860
P304
P356
10.1371/JOURNAL.PONE.0169624
P407
P577
2017-01-13T00:00:00Z